In the world of upstart pharmaceuticals and healthcare companies, timing is everything. These firms often struggle for an ...

Absci reported quarterly losses of 25 cents per share which missed the analyst consensus estimate of 23 cents per share. This is unchanged from the same period last year. The company reported ...

Absci Corp. (($ABSI)) has held its Q4 earnings call. Read on for the main highlights of the call. Absci Corp’s recent earnings call presented a ...

The company also announced a collaboration with chipmaker AMD to power its advanced de novo AI antibody design models, as well as AI biotechnology company Owkin to co-develop therapeutic candidates ...

Absci Corp (NASDAQ:ABSI) is set to release its Q4 2024 earnings on Mar 18, 2025. The consensus estimate for Q4 2024 revenue ...

Thank you for standing by and welcome to Absci’s Fourth Quarter and Full Year 2024 Business Update and Financial Operating Results Conference call. At this time, all participants are in listen ...

Pre-earnings options volume in AbSci Corp is normal with calls leading puts 8:3. Implied volatility suggests the market is anticipating a move near 16.5%, or 51c, after results ar ...

Absci (NASDAQ:ABSI – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at Guggenheim in a research ...

Ratings for Absci (NASDAQ:ABSI) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table encapsulates their recent ratings ...

Unveiled updates across proprietary pipeline and demonstrated new breakthroughs by AI platform at 2024 R&D Day Entered into collaboration with AMD, including $20 million strategic investment in Absci ...

VANCOUVER, Wash. and NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be ...

VANCOUVER, Wash. and NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced that on March 3, 2025 ...